OBJECTIVE: to develop an electronic medical record for patients living with HIV, HBV or HCV in order to improve their management, facilitate communication between all the caregivers, and to create a useful medical database for research and assessments. This project (NADIS 2000) involved 6 centres of Infectious Diseases in France in partnership with Fédialis Médica (subsidiary of the GSK group in France). METHODS: A specifications sheets was drawn-up by a piloting Committee regrouping the various correspondents in each centre and a computer expert representing Fédialis Médica. A Scientific and Development committee regrouped the heads of departments of each centre and the representatives from Fédialis Médica and GSK and was charged with defining the general concept of the project and guaranteeing the scientific and clinical aspects. RESULTS: NADIS 2000 version 1.0 was activated in the departments of infectious diseases in Nice and Toulouse in November 2000 and in others Units at the end of 2001. NADIS 2000 permitted real-time use by the physicians in the Outpatients and Day-care Units and was easily handled by all the practitioners. Its use was eased by the principles clearly defined before its application (department project, progressive but exhaustive use), an intuitive interface simulating a consultation, and functions proposing direct benefits for the physicians (graphical visualization of the biological variables, printing of prescriptions and letters). CONCLUSION: The activation and input methods of NADIS 2000 are user friendly and the physicians find it rapidly easy to use. New functional aspects are being developed as well as its use in other hospital departments.
OBJECTIVE: to develop an electronic medical record for patients living with HIV, HBV or HCV in order to improve their management, facilitate communication between all the caregivers, and to create a useful medical database for research and assessments. This project (NADIS 2000) involved 6 centres of Infectious Diseases in France in partnership with Fédialis Médica (subsidiary of the GSK group in France). METHODS: A specifications sheets was drawn-up by a piloting Committee regrouping the various correspondents in each centre and a computer expert representing Fédialis Médica. A Scientific and Development committee regrouped the heads of departments of each centre and the representatives from Fédialis Médica and GSK and was charged with defining the general concept of the project and guaranteeing the scientific and clinical aspects. RESULTS:NADIS 2000 version 1.0 was activated in the departments of infectious diseases in Nice and Toulouse in November 2000 and in others Units at the end of 2001. NADIS 2000 permitted real-time use by the physicians in the Outpatients and Day-care Units and was easily handled by all the practitioners. Its use was eased by the principles clearly defined before its application (department project, progressive but exhaustive use), an intuitive interface simulating a consultation, and functions proposing direct benefits for the physicians (graphical visualization of the biological variables, printing of prescriptions and letters). CONCLUSION: The activation and input methods of NADIS 2000 are user friendly and the physicians find it rapidly easy to use. New functional aspects are being developed as well as its use in other hospital departments.
Authors: Klaus Jansen; Anders Sönnerborg; Norbert Brockmeyer; Anders Thalme; Veronica Svedhem; Stephan Dupke; Jean-Luc Eychenne; Tina Nakonz; Maria Jesus Jimenez-Exposito; Pascal Pugliese Journal: AIDS Res Hum Retroviruses Date: 2012-11-27 Impact factor: 2.205
Authors: H Melliez; A Duhamel; O Robineau; L Bocket; I Kim; E Sauser; F Loiseleur; N Viget; A Pasquet; E Senneville; D Seguy Journal: Eur J Clin Microbiol Infect Dis Date: 2017-06-24 Impact factor: 3.267
Authors: Isabelle Poizot-Martin; Clotilde Allavena; Cyrille Delpierre; Claudine Duvivier; Véronique Obry-Roguet; Carla E Cano; Francine Guillouet de Salvador; David Rey; Pierre Dellamonica; Antoine Cheret; Lise Cuzin; Christine Katlama; André Cabié; Bruno Hoen Journal: Medicine (Baltimore) Date: 2016-10 Impact factor: 1.889
Authors: Isabelle Poizot-Martin; Clotilde Allavena; Claudine Duvivier; Carla Eliana Cano; Francine Guillouet de Salvador; David Rey; Pierre Dellamonica; Lise Cuzin; Antoine Cheret; Bruno Hoen Journal: PLoS One Date: 2016-11-08 Impact factor: 3.240
Authors: Paolo Fraccaro; Valeria Pupella; Roberta Gazzarata; Chiara Dentone; Giovanni Cenderello; Pasqualina De Leo; Federica Bozzano; Giorgetta Casalino Finocchio; Andrea De Maria; Daniela Fenoglio; Gilberto Filaci; Michele Guerra; Antonio Di Biagio; Eugenio Mantia; Giancarlo Orofino; Giuseppe Ferrea; Claudio Viscoli; Mauro Giacomini Journal: Med 2 0 Date: 2013-08-13